-
公开(公告)号:US5686606A
公开(公告)日:1997-11-11
申请号:US682514
申请日:1996-07-12
申请人: Tamio Mizukami , Mikito Itoh , Mitsunobu Hara , Hirofumi Nakano , Yumiko Aotani , Keiko Ochiai , Shiro Akinaga , Akira Mihara
发明人: Tamio Mizukami , Mikito Itoh , Mitsunobu Hara , Hirofumi Nakano , Yumiko Aotani , Keiko Ochiai , Shiro Akinaga , Akira Mihara
IPC分类号: C07D225/06 , C12P17/10 , A61K31/415
CPC分类号: C07D225/06 , C12P17/10
摘要: The present invention relates to UCF116 compounds represented by the formula (I) : ##STR1## wherein an example of Q.sup.1 representation is ##STR2## and an example of Q.sup.2 representation is ##STR3## which have antibacterial and antitumor activity and are useful as antibacterial and antitumor agents.
摘要翻译: PCT No.PCT / JP95 / 02325 Sec。 371日期:1996年7月12日 102(e)日期1996年7月12日PCT提交1995年11月14日PCT公布。 公开号WO96 / 15114 日期:1996年5月23日本发明涉及由式(I)表示的UCF116化合物:其中Q1表示的实例是活性并可用作抗细菌剂和抗肿瘤剂。
-
公开(公告)号:US5719179A
公开(公告)日:1998-02-17
申请号:US772941
申请日:1996-12-24
申请人: Tamio Mizukami , Yasushi Sakai , Tetsuo Yoshida , Youichi Uosaki , Keiko Ochiai , Shiro Akinaga
发明人: Tamio Mizukami , Yasushi Sakai , Tetsuo Yoshida , Youichi Uosaki , Keiko Ochiai , Shiro Akinaga
IPC分类号: C07D407/06 , C07D407/14 , C12P17/06 , C07D407/04 , A61K31/35
CPC分类号: C07D407/06 , C07D407/14 , C12P17/06
摘要: Disclosed is Compound GEX1 of formula (I), having excellent antitumor activity: ##STR1## wherein R.sup.1 represents hydroxy or ##STR2## R.sup.2, R.sup.3 and R.sup.4 independently represent hydrogen or hydroxy; R.sup.5 represents hydroxyl or lower alkoxy; provided that when R.sup.1 is hydroxy and R.sup.5 is methoxy, then at least one of R.sup.2, R.sup.3 and R.sup.4 is the group except for hydrogen, and pharmaceutically acceptable salts thereof.
摘要翻译: 公开了具有优异抗肿瘤活性的式(I)化合物GEX1:其中R 1表示羟基或R 2,R 3和R 4各自独立地表示氢或羟基; R5代表羟基或低级烷氧基; 条件是当R 1为羟基且R 5为甲氧基时,则R 2,R 3和R 4中的至少一个为氢以外的基团,及其药学上可接受的盐。
-
公开(公告)号:US5665703A
公开(公告)日:1997-09-09
申请号:US567529
申请日:1995-12-05
申请人: Tamio Mizukami , Yasushi Sakai , Tetsuo Yoshida , Tsutomu Agatsuma , Keiko Ochiai , Shiro Akinaga
发明人: Tamio Mizukami , Yasushi Sakai , Tetsuo Yoshida , Tsutomu Agatsuma , Keiko Ochiai , Shiro Akinaga
IPC分类号: A61K38/00 , A61P31/04 , A61P35/00 , C07K7/06 , C07K11/00 , C07K14/195 , C07K14/41 , C07K11/02
摘要: A GE3 compound of the formula (I) having antibacterial and antitumor properties: ##STR1##
摘要翻译: 具有抗细菌和抗肿瘤性质的式(I)的GE3化合物:其中:(I)
-
公开(公告)号:US5663298A
公开(公告)日:1997-09-02
申请号:US730348
申请日:1996-10-15
申请人: Tamio Mizukami , Akira Asai , Yoshinori Yamashita , Ritsuko Katahira , Atsuhiro Hasegawa , Keiko Ochiai , Shiro Akinaga
发明人: Tamio Mizukami , Akira Asai , Yoshinori Yamashita , Ritsuko Katahira , Atsuhiro Hasegawa , Keiko Ochiai , Shiro Akinaga
CPC分类号: C07K5/06026 , A61K38/00
摘要: The present invention relates to UCK14 compounds having antitumor activity which are represented by the formula: ##STR1## wherein R.sup.1 is hydrogen or --COOC(CH.sub.3).sub.3 ; and R.sup.2 and R.sup.3 are taken together to form --CH.sub.2 --, or each R.sup.2 and R.sup.3 independently are hydrogen,and pharmaceutically acceptable salts thereof.
摘要翻译: 本发明涉及具有抗肿瘤活性的UCK14化合物,其由下式表示:其中R 1为氢或-COOC(CH 3)3; 并且R 2和R 3一起形成-CH 2 - ,或每个R 2和R 3独立地是氢,及其药学上可接受的盐。
-
公开(公告)号:US5798379A
公开(公告)日:1998-08-25
申请号:US994029
申请日:1997-12-18
申请人: Tamio Mizukami , Harumi Ogawa , Ryuichiro Nakai , Akira Asai , Yoshinori Yamashita , Katsuhiko Ando , Tsutomu Agatsuma , Shiro Akinaga , Kozo Ouchi , Hideki Kawasaki
发明人: Tamio Mizukami , Harumi Ogawa , Ryuichiro Nakai , Akira Asai , Yoshinori Yamashita , Katsuhiko Ando , Tsutomu Agatsuma , Shiro Akinaga , Kozo Ouchi , Hideki Kawasaki
IPC分类号: C07D487/04 , C07D491/16 , C12P17/14 , A61K31/40 , C07D487/02
CPC分类号: C07D487/04 , C12P17/14
摘要: UCS1025 compounds represented by the following formula (I): ##STR1## wherein R represents hydrogen or hydroxyl group, or tautomers or pharmacologically acceptable salts thereof.
摘要翻译: 由下式(I)表示的UCS1025化合物:其中R表示氢或羟基,或互变异构体或其药理学上可接受的盐。
-
公开(公告)号:US5977165A
公开(公告)日:1999-11-02
申请号:US958285
申请日:1997-10-27
申请人: Tsutomu Agatsuma , Yutaka Saitoh , Yoshinori Yamashita , Tamio Mizukami , Shiro Akinaga , Katsushige Gomi , Kazuhito Akasaka , Isami Takahashi
发明人: Tsutomu Agatsuma , Yutaka Saitoh , Yoshinori Yamashita , Tamio Mizukami , Shiro Akinaga , Katsushige Gomi , Kazuhito Akasaka , Isami Takahashi
IPC分类号: C07D313/00 , A61K31/335
CPC分类号: C07D313/00
摘要: The present invention relates to radicicol derivatives represented by the following formula (I) or pharmacologically acceptable salts thereof: ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and each represents hydrogen, alkanoyl, alkenoyl or tert-butyldimethylsilyl; (1) when X represents halogen, Y represents an oxygen atom or R.sup.4 --O--N (wherein R.sup.4 represents hydrogen or substituted or unsubstituted lower alkyl); and R.sup.3 represents hydrogen, alkanoyl, alkenoyl or the like; and (2) when X and R.sup.3 are combined with each other to represent a single bond; Y represents R.sup.4B --O--N (wherein R.sup.4B has the same meaning as R.sup.4). The radicicol derivatives of the present invention demonstrate tyrosine kinase inhibition activity and pharmacological activities such as antitumor, antimicrobial or immunosuppression effects.
摘要翻译: 本发明涉及由下式(I)表示的根赤壳菌素衍生物或其药理学上可接受的盐:其中R1和R2相同或不同,各自代表氢,烷酰基,烯酰基或叔丁基二甲基甲硅烷基; (1)当X表示卤素时,Y表示氧原子或R4-O-N(其中R4表示氢或取代或未取代的低级烷基); 和R3表示氢,烷酰基,烯酰基等; 和(2)当X和R 3相互结合以表示单键时; Y表示R4B-O-N(其中R4B与R4相同)。 本发明的根皮霉素衍生物显示出酪氨酸激酶抑制活性和药理活性,如抗肿瘤,抗微生物或免疫抑制作用。
-
公开(公告)号:US20050070591A1
公开(公告)日:2005-03-31
申请号:US10498874
申请日:2002-12-17
申请人: Fumihiko Kanai , Chikara Murakata , Tetsuya Tsujita , Yoshinori Yamashita , Shiro Akinaga , Tamio Mizukami
发明人: Fumihiko Kanai , Chikara Murakata , Tetsuya Tsujita , Yoshinori Yamashita , Shiro Akinaga , Tamio Mizukami
IPC分类号: A61K31/407 , A61K31/409 , A61K31/4196 , A61K31/422 , A61K31/4439 , A61K31/497 , A61K31/5377 , A61K31/541 , A61P25/00 , A61P35/00 , A61P43/00 , C07D403/04 , C07D487/04 , C07D487/22 , C07D487/02
CPC分类号: C07D403/04 , A61K31/407 , A61K31/409 , A61K31/4196 , A61K31/422 , A61K31/4439 , A61K31/497 , A61K31/5377 , A61K31/541 , C07D487/04
摘要: There is provided an indole derivative represented by the above formula (I) or a pharmaceutically acceptable salt thereof which is useful for the treatment of malignant tumor or a brain neurodegenerative disease: (wherein C ring represents a benzene ring or a cyclohexene ring; X and Y are the same or different and each represent —CH2—, —CH(OH)—, —CH(ORx)—, —CH(SRY)— or carbonyl; R1 and R2 are the same or different and each represent a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkenyl or substituted or unsubstituted lower alkanoyl or R1 and R2 form a benzene ring together two carbon atoms each being adjacent thereto; and R3, R4 and R5 are the same or different and each represent a hydrogen atom, substituted or unsubstituted lower alkyl, etc.)
摘要翻译: 提供上述式(I)表示的吲哚衍生物或其药学上可接受的盐,其可用于治疗恶性肿瘤或脑神经变性疾病:(其中C环表示苯环或环己烯环; X和 Y相同或不同,各自表示-CH 2 - , - CH(OH) - , - CH(OR x) - , - CH(R 3 Y) - 或羰基; R 1和R 2 各自表示氢原子,取代或未取代的低级烷基,取代或未取代的低级链烯基或取代或未取代的低级烷酰基或R 1和R 2共同形成两个碳原子的苯环, R 3,R 4和R 5相同或不同,各自表示氢原子,取代或未取代的低级烷基等)
-
公开(公告)号:US5965604A
公开(公告)日:1999-10-12
申请号:US215468
申请日:1998-12-17
申请人: Yoshinori Yamashita , Ryuichiro Nakai , Tamio Mizukami , Shingo Kakita , Shigeru Chiba , Shiro Akinaga
发明人: Yoshinori Yamashita , Ryuichiro Nakai , Tamio Mizukami , Shingo Kakita , Shigeru Chiba , Shiro Akinaga
IPC分类号: A61K31/365 , A61P31/04 , A61P35/00 , C07D493/18 , C07D493/20 , C12P17/18 , C12R1/465 , A01N43/08 , A01N43/02 , C07D307/77 , C12P17/08
CPC分类号: C07D493/20 , C12P17/181 , C12R1/465 , Y10S435/886
摘要: The present invention relates to chrolactomycin compound represented by the following formula (I): ##STR1## or pharmaceutically acceptable salts thereof having antibacterial and antitumor activities.
摘要翻译: 本发明涉及由下式(I)表示的己内酰霉素化合物或其药学上可接受的盐,其具有抗细菌和抗肿瘤活性。
-
公开(公告)号:US06492392B1
公开(公告)日:2002-12-10
申请号:US09481542
申请日:2000-01-12
申请人: Yutaka Kanda , Rieko Tanaka , Mitsunobu Hara , Jun Eishima , Shiro Akinaga , Tadashi Ashizawa
发明人: Yutaka Kanda , Rieko Tanaka , Mitsunobu Hara , Jun Eishima , Shiro Akinaga , Tadashi Ashizawa
IPC分类号: A61K31445
CPC分类号: C07D401/14 , C07D231/12 , C07D233/56 , C07D249/08 , C07D401/06 , C07D405/14 , C07D409/14
摘要: The present invention provides 2-piperidone compounds or pharmaceutically acceptable salts thereof, which have a potent activity of inhibiting the proliferation of tumor cells and thus are useful as medicaments, as well as antitumor agents containing these compounds. The 2-piperidone compound is represented by the following formula (I): wherein R1 represents —(CH2)nR1a {wherein n is an integer of from 0 to 5, and R1a represents amino, lower alkylamino, di(lower alkyl)amino, substituted or unsubstituted aryl, or a substituted or unsubstituted heterocyclic group}, and R2 and R3 independently represent lower alkyl which may be substituted by lower alkoxycarboyl; lower alkenyl, aralkyl or lower alkynyl which may be substituted by substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group; substituted or unsubstituted aryl; or a substituted or unsubstituted heterocyclic group.
摘要翻译: 本发明提供了具有抑制肿瘤细胞增殖的有效活性的2-哌啶酮化合物或其药学上可接受的盐,因此可用作药物,以及含有这些化合物的抗肿瘤剂。 2-哌啶酮化合物由下式(I)表示:其中R1表示 - (CH2)nR1a {其中n为0-5的整数,R1a表示氨基,低级烷基氨基,二(低级烷基)氨基,取代的 或未取代的芳基,或取代或未取代的杂环基},R2和R3独立地表示可以被低级烷氧基羰基取代的低级烷基; 可被取代或未取代的芳基或取代或未取代的杂环基取代的低级烯基,芳烷基或低级炔基; 取代或未取代的芳基; 或取代或未取代的杂环基。
-
公开(公告)号:US06861530B2
公开(公告)日:2005-03-01
申请号:US09899186
申请日:2001-07-06
申请人: Shinji Nara , Rieko Nakatsu , Yutaka Kanda , Shiro Akinaga , Mitsunobu Hara , Jun Eishima , Timothy A. Grese , Douglas L. Gernert
发明人: Shinji Nara , Rieko Nakatsu , Yutaka Kanda , Shiro Akinaga , Mitsunobu Hara , Jun Eishima , Timothy A. Grese , Douglas L. Gernert
IPC分类号: C07D211/38 , A61K31/451 , A61K31/454 , A61K31/4545 , A61P35/00 , C07D401/04 , C07D401/06 , C07D401/14 , C07D405/14 , C07D409/14 , C07D417/14 , C07D211/68 , C07D211/80 , C07D213/02 , C07D401/00 , C07D409/00
CPC分类号: C07D211/38 , C07D401/04 , C07D401/06 , C07D401/14 , C07D405/14 , C07D409/14 , C07D417/14
摘要: This invention relates to substituted piperidine derivatives having at least one six-membered ring substituent. The piperidine derivatives exhibit antitumor activity and are useful as pharmaceuticals such as an antitumor agent.
摘要翻译: 本发明涉及具有至少一个六元环取代基的取代哌啶衍生物。 哌啶衍生物显示出抗肿瘤活性,并且可用作药物如抗肿瘤剂。
-
-
-
-
-
-
-
-
-